Advertisement
Screener

Avant Diagnostics, Inc Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues

Avant Diagnostics, Inc Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues

Avant Diagnostics, Inc reported Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues of $20.00 thousand for the 3-month period ending 2017-12-31, per its 10-Q filed 2018-12-28.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Purchases, Sales, Issues, Settlements

us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues · last filed 2018-12-28

  • Avant Diagnostics, Inc fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, issues for the quarter ending 2017-12-31 was $20.00K.
  • Avant Diagnostics, Inc fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, issues for the quarter ending 2017-09-30 was $1.51M.
  • Avant Diagnostics, Inc fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, issues for fiscal 2017 was $1.83M.
Period endFair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues 3 monthFair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues 6 monthFair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues 9 monthFair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues 12 month
2017-12-31$20.00K
10-Q · filed 2018-12-28
$1.53M
derived: sum of 2 quarters · filed 2018-12-28
2017-09-30$1.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-04
$1.83M
10-K · filed 2018-12-04
2017-06-30$325.00K
10-Q · filed 2018-12-04